Zydus Lifesciences gets USFDA nod to market chronic heart failure treatment drug

Zydus Lifesciences Ltd has received final approval from the USFDA to market its generic Sacubitril and Valsartan tablets for treating chronic heart failure in adults. The tablets come in strengths of 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg. The drug will be manufactured in Ahmedabad.